Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX
$13.75
+1.70%
at last close
Financials (TTM)
- Revenue
- $3.05 billion
- Net Income
- $181.31 million
- Net Margin
- 5.95%
- Return on Equity
- -394.43%
- Debt-to-Equity
- -55.95
- P/E Ratio
- 36.18
- Price / Book
- -95.42
- Price / Sales
- 1.44
Over the trailing twelve months, Amneal Pharmaceuticals, Inc. Class A Common Stock generated revenue of $3.05 billion and net income of $181.31 million, a net margin of 5.95%.
At the last closing price of $13.75, AMRX trades at 36.18 times trailing earnings and 1.44 times sales, with a market capitalization of $4.39 billion.
Key Stats
- Last Close
- $13.75
- Market Cap
- $4.39 billion
- 52-Week Range
- $7.02 – $15.42
- Average Volume
- 1.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.